Publications

A phase 1 study of NOX66 in combination with carboplatin in patients with end stage solid tumours

Poster at COSA Annual Meeting Perth November 2018

Trial in Progress: NOX66 in combination with Palliative Radiotherapy in patients with CRPC – a Phase 1 safety and dose finding study

Poster at COSA Annual Meeting Perth November 2018

NOX66 and Palliative Radiotherapy in Patients with Late-Stage Prostate Cancer- A Phase 1b Proof of Concept and Dose Confirmation Study

Poster presented at Australian and New Zealand Urogenital and Prostate Cancer (ANZUP) Clinical Trials Group Annual Scientific Meeting, Sydney. July 8-10 2018

A phase 1 study of NOX66 in combination with carboplatin in patients with end stage solid tumours

End- of- study clinical data. Poster at the American Society of Clinical Oncology (ASCO) Annual Meeting
Chicago. June 1-5, 2018

NOX66 Plus Low Dose Carboplatin CEP-1 Study Interim Trial Results

Poster at ESMO 2018 International Congress on Targeted Anticancer Therapies,
Paris.  March 5-7, 2018

NOX66 Plus Carboplatin - Phase 1 Signalling Study

 Oral Presentation at ESMO Asia 2017 Conference
 Singapore, November 17-19   2017

Idronoxil levels of patients receiving NOX66

Poster at the Clinical Oncology Society of Australia ( COSA) Annual Scientific Meeting
Sydney, Australia. November 13-15, 2017

ENOX2 levels of patients receiving NOX66

Poster at the Clinical Oncology Society of Australia ( COSA) Annual Scientific Meeting
Sydney, Australia. November 13-15, 2017

Trial Design: Safety of NOX66 in Combination with Palliative Dose Radiotherapy - A Phase 1 Dose Escalation Study

Poster at the Clinical Oncology Society of Australia ( COSA) Annual Scientific Meeting
Sydney, Australia. November 13-15, 2017

Chemosensitization of Carboplatin by NOX66

Poster at the European Society for Medical Oncology 2017 (ESMO) Congress
Madrid, Spain. September 8-12, 2017